BNO 106

BNO 106
Uloga funkcionalne genomike u onkologiji
dr. sc. Marijeta Kralj, znanstveni savjetnik
Suradnica: dr. sc. Koraljka Gall Trošelj, znanstvena savjetnik
Ukupno 18 sati, 14 sati predavanja 4 sata seminara
ECTS: 2
Ishodi učenja:
Osnovna znanja o funkcionalnoj genomici koja se temelji na pokusima kojima je obuhvaćen širok raspon gena i/ili proteina i računalnoj analizi dobivenih podataka
Znanje o novim tehnologijama širokog raspona i primjeni u istraživanju stanične funkcije u zdravlju i bolesti.  Saznanja o potrebi interdisciplinarnih istraživanja i računalne obradbe podataka.
Ukupno 18 sati, 14 sati predavanja 4 sata seminara
Literatura:
1. Cole SW. Human social genomics. PLoS Genet. 2014 Aug 28;10(8):e1004601.
2. McGuire A, Brown JA, Kerin MJ. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastasis Rev 2015;34(1):145-55.
3. Yang Y, Dong X, Xie B, Ding N, Chen J, Li Y, Zhang Q, Qu H, Fang X. Databases and Web Tools for Cancer Genomics Study. Genomics Proteomics Bioinformatics. 2015;13(1):46-504.
5. Hayes DN, Kim WY. The next steps in next-gen sequencing of cancer genomes. J Clin Invest 2015; 125(2):462-8.
6. Reinhold WC, Varma S, Rajapakse VN, Luna A, Sousa FG, Kohn KW, Pommier YG. Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer. Hum Genet. 2015;134(1):3-11.
7. Chae YK, Gonzalez-Angulo AM. Implications of functional proteomics in breast cancer. Oncologist. 2014;19(4):328-35.
8. Guo S, Zou J, Wang G. Advances in the proteomic discovery of novel therapeutic targets in cancer. Drug Des Devel Ther 2013;7:1259-71.
9. Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 2008;5(10):588-99. Ispiši stranicu